# ScoreItem: Vulva e Estruturas Externas

**ID:** `019bf31d-2ef0-7078-b942-860ee56136a4`
**FullName:** Vulva e Estruturas Externas (Hist√≥rico de doen√ßas - Hist√≥rico de sa√∫de (Questionar ativamente sobre doen√ßas/sintomas - passado ou atual): - Genit√°lia feminina)

**Preparation Metadata:**
- Quality Grade: **EXCELLENT**
- Total Chunks: 30 de 2 artigos
- Avg Similarity: 0.647

---

## Contexto

Voc√™ √© um especialista em medicina funcional integrativa e est√° contribuindo com o **Escore Plenya** ‚Äî um escore completo de an√°lise de sa√∫de que avalia todos os aspectos da sa√∫de, performance e longevidade humana. Cada ScoreItem representa um par√¢metro cl√≠nico, laboratorial, gen√©tico, comportamental ou hist√≥rico que comp√µe esse escore.

Seu papel √© gerar conte√∫do cl√≠nico de alta qualidade para enriquecer cada par√¢metro do escore com relev√¢ncia cl√≠nica, orienta√ß√£o ao paciente e conduta pr√°tica.

**Regras inegoci√°veis:**
- Use **apenas** o conhecimento m√©dico real consolidado e os dados presentes nos chunks cient√≠ficos abaixo
- **N√£o alucine, n√£o invente** dados, estudos, estat√≠sticas ou refer√™ncias que n√£o estejam nos chunks ou no seu conhecimento m√©dico estabelecido
- Se um dado espec√≠fico n√£o constar nos chunks e n√£o for do seu conhecimento consolidado, **n√£o o inclua**
- Seja preciso: prefira omitir a inventar

## Instru√ß√£o

Com base nos chunks cient√≠ficos abaixo, gere as respostas em formato JSON.

**O JSON deve obrigatoriamente conter o campo `score_item_id` com o valor `019bf31d-2ef0-7078-b942-860ee56136a4`.**

```json
{
  "score_item_id": "019bf31d-2ef0-7078-b942-860ee56136a4",
  "clinical_relevance": "Texto t√©cnico para m√©dicos (1000-5000 chars): defini√ß√£o fisiol√≥gica precisa, valores de refer√™ncia e interpreta√ß√£o, fisiopatologia resumida, dados epidemiol√≥gicos com n√∫meros concretos, estratifica√ß√£o de risco baseada em evid√™ncias.",
  "points": 1,
  "patient_explanation": "Texto simples para pacientes (500-1000 chars): o que √© este par√¢metro sem jarg√µes, por que √© importante para a sa√∫de, o que valores alterados podem significar. Tom tranquilizador e educativo.",
  "conduct": "Conduta cl√≠nica em Markdown (1000-5000 chars): investiga√ß√£o complementar necess√°ria, crit√©rios de encaminhamento a especialistas, interven√ß√µes baseadas em evid√™ncias. Use bullet points, se√ß√µes e negrito."
}
```

**Regras para `points` (1-50):**
- Baixo impacto cl√≠nico: 1-9 pts
- Alto impacto cl√≠nico: 10-19 pts
- Alto impacto em mortalidade: 20-50 pts
- Crit√©rios: gravidade/mortalidade (40%), preval√™ncia (30%), intervencionabilidade (30%)

---

### Contexto Cient√≠fico

**ScoreItem:** Vulva e Estruturas Externas (Hist√≥rico de doen√ßas - Hist√≥rico de sa√∫de (Questionar ativamente sobre doen√ßas/sintomas - passado ou atual): - Genit√°lia feminina)

**30 chunks de 2 artigos (avg similarity: 0.647)**

### Chunk 1/30
**Article:** Lichen sclerosus: The 2023 update (2023)
**Journal:** Frontiers in Medicine
**Section:** results | **Similarity:** 0.699

1097/
JW9.0000000000000042
 224. Hagedorn, M, Buxmeyer, B, Schmitt, Y, and Bauknecht, T. Survey of genital lichen 
sclerosus in women and men. 
Arch Gynecol Obstet
. (2002) 266:86¬ñ91. doi: 
10.1007/
s004040100209
 225. Burrows, LJ, Creasey, A, and Goldstein, AT. e treatment of vulvar lichen sclerosus and 
female sexual dysfunction. 
J Sex Med
. (2011) 8:219¬ñ22. doi: 
10.1111/j.1743-6109.2010.02077.x
 226. van Cranenburgh, OD, Nijland, SBW, Lindeboom, R, de Korte, J, de Rie, MA, Ter 
Stege, JA, et al. Patients with lichen sclerosus experience moderate satisfaction with 
treatment and impairment of quality of life: results of a cross-sectional study. 
Br J Dermatol
. 
(2017) 176:1508¬ñ15. doi: 
10.1111/bjd.15125
 227. Mangera, A, Osman, N, and Chapple, C. Recent advances in understanding 
urethral lichen sclerosus. 
F1000Res
. (2016) 5:96. doi: 
10.12688/f1000research.7120.1
 228. Jones, RW, Scurry, J, Neill, S, and MacLean, AB.

---

### Chunk 2/30
**Article:** 2021 European guideline for the management of vulval conditions (2022)
**Journal:** Journal of the European Academy of Dermatology and Venereology
**Section:** results | **Similarity:** 0.699

lichensclerosus:theresultsofarandomizedstudy
comparingtopicalvitaminEwithanemollient.EurJDermatol2013;23:189‚Äì194.63ChiCC,KirtschigG,BaldoM,BrackenburyF,LewisF,WojnarowskaF.Topicalinterventionsforgenitallichensclerosus(Review).CochraneDatabaseSystRev2011:CD008240.64LewisFM,TatnallFM,VelangiSSetal.Britishassociationofdermatol-ogistsguidelinesforthemanagementoflichensclerosus,2018.BrJDer-matol2018;178:839‚Äì853.65VirgiliA,BorghiA,ToniG,MinghettiS,CorazzaM.Firstrandomizedtrialonclobetasolpropionateandmometasonefuroateinthetreatment
ofvulvarlichensclerosus:resultsofefÔ¨Åcacyandtolerability.BrJDerma-tol2014;171:388‚Äì396.¬©2022EuropeanAcademyofDermatologyandVenereologyJEADV2022
VulvalconditionsEuropeanguideline17

66VirgiliA,MinghettiS,BorghiA,CorazzaM.Proactivemaintenancetherapywithatopicalcorticosteroidforvulvarlichensclerosus:prelimi-
naryresultsofarandomizedstudy.BrJDermatol2013;168:1316‚Äì1324.67FunaroD,LovettA,LerouxN,PowellJ.Adouble-blind,randomizedprospectivestudyevaluatingtopicalc

---

### Chunk 3/30
**Article:** 2021 European guideline for the management of vulval conditions (2022)
**Journal:** Journal of the European Academy of Dermatology and Venereology
**Section:** results | **Similarity:** 0.697

susandautoimmunity‚Äìastudyof350women.BrJDermatol1988;118:41‚Äì46.57WallaceHJ.Lichensclerosusetatrophicus.TransStJohnsHospDerma-tolSoc1971;57:9‚Äì30.58RegauerS,ReichO.Earlyvulvarlichensclerosus:ahistologicalchal-lenge.Histopathology2005;47:340‚Äì347.59LeeA,BradfordJ,FischerG.Long-termmanagementofadultvulvarlichensclerosus:aprospectivecohortstudyof507women.JAMADer-matol2015;151:1061‚Äì1067.60CooperSM,AliI,BaldoM,WojnarowskaF.Theassociationoflichensclerosusanderosivelichenplanusofthevulvawithautoimmunedis-
ease:acase-controlstudy.ArchDermatol2008;144:1432‚Äì1435.61KalowitzBieberA,SteuerAB,MelnickLE,WongPW,KeltzPomeranzMK.Autoimmuneanddermatologicconditionsassociatedwithlichensclerosus.JAmAcadDermatol2021;85:228‚Äì229.62VirgiliA,MinghettiS,BorghiA,CorazzaM.Long-termmaintenancetherapyforvulvarlichensclerosus:theresultsofarandomizedstudy
comparingtopicalvitaminEwithanemollient.EurJDermatol2013;23:189‚Äì194.63ChiCC,KirtschigG,BaldoM,BrackenburyF,LewisF,WojnarowskaF.Topicalinterventionsforgen

---

### Chunk 4/30
**Article:** Lichen sclerosus: The 2023 update (2023)
**Journal:** Frontiers in Medicine
**Section:** results | **Similarity:** 0.691

udek, I, Apalla, Z, Gourhant, JY, Longo, C, et al. 
Dermoscopic patterns of granuloma annulare and necrobiosis lipoidica. 
Clin Exp Dermatol
. 
(2013) 38:425¬ñ7. doi: 
10.1111/ced.12126
 146. Smith, YR, and Quint, EH. Clobetasol propionate in the treatment of premenarchal 
vulvar lichen sclerosus. 
Obstet Gynecol
. (2001) 98:588¬ñ91. doi: 
10.1016/s0029-7844(01)01496-x
 147. Bradford, J, and Fischer, G. Long-term management of vulval lichen sclerosus in adult 
women. 
Aust N Z J Obstet Gynaecol
. (2010) 50:148¬ñ52. doi: 
10.1111/j.1479-828X.2010.01142.x
 148. Virgili, A, Borghi, A, Toni, G, Minghetti, S, and Corazza, M. First randomized trial 
on clobetasol propionate and mometasone furoate in the treatment of vulvar lichen 
sclerosus: results of ecacy and tolerability. 
Br J Dermatol
. (2014) 171:388¬ñ96. doi: 
10.1111/bjd.12910
 149. Mashayekhi, S, Flohr, C, and Lewis, FM. e treatment of vulval lichen sclerosus in 
prepubertal girls: a critically appraised topic. 
Br J Dermatol
.

---

### Chunk 5/30
**Article:** 2021 European guideline for the management of vulval conditions (2022)
**Journal:** Journal of the European Academy of Dermatology and Venereology
**Section:** results | **Similarity:** 0.676

rticosteroidforvulvarlichensclerosus:prelimi-
naryresultsofarandomizedstudy.BrJDermatol2013;168:1316‚Äì1324.67FunaroD,LovettA,LerouxN,PowellJ.Adouble-blind,randomizedprospectivestudyevaluatingtopicalclobetasolpropionate0.05%versus
topicaltacrolimus0.1%inpatientswithvulvarlichensclerosus.JAmAcadDermatol2014;71:84‚Äì91.68HenggeUR,KrauseW,HofmannHetal.Multi-centre,phaseIItrialonthesafetyandefÔ¨Åcacyoftopicaltacrolimusointmentforthetreatment
oflichensclerosus.BrJDermatol2006;155:1021‚Äì1028.69LiY,XiaoY,WangH,LiH,LuoX.Low-concentrationtopicaltacroli-musforthetreatmentofanogenitallichensclerosusinchildhood:main-tenancetreatmenttoreducerecurrence.JPediatrAdolescGynecol2013;26:239‚Äì242.70GoldsteinAT,CreaseyA,PfauR,PhillipsD,BurrowsLJ.Adouble-blind,randomizedcontrolledtrialofclobetasolversuspimecrolimusin
patientswithvulvarlichensclerosus.JAmAcadDermatol2011;64:99‚Äì104.71NissiR,RisteliJ,NiemimaaM.Pimecrolimuscream1%inthetreat-mentoflichensclerosus.GynecolObstetInvest2006;63:151‚Äì154.72EdeyK,

---

### Chunk 6/30
**Article:** 2021 European guideline for the management of vulval conditions (2022)
**Journal:** Journal of the European Academy of Dermatology and Venereology
**Section:** results | **Similarity:** 0.673

?Adipose-derivedstemcellsandplatelet-richplasmaforthetreatmentofvulvarlichensclerosus.JLowGenitTractDis2019;23:65‚Äì70.82KreuterA,GambichlerT,SauermannKetal.Extragenitallichensclero-sussuccessfullytreatedwithtopicalcalcipotriol:evaluationbyinvivoconfocallaserscanningmicroscopy.BrJDermatol2002;146:332‚Äì333.83TrokoudesD,LewisFM.Lichensclerosus-thecourseduringpregnancyandeffectondelivery.JEurAcadDermatolVenereol2019;33:e466‚Äìe468.84SimpsonRC,CooperSM,KirtschigGetal.Futureresearchprioritiesforlichensclerosus-resultsofaJamesLindAlliancePrioritySetting
Partnership.BrJDermatol2018;180:1236‚Äì1237.85GoodrumCA,LeightonPA,SimpsonRC.Outcomedomainsinlichensclerosus.BrJDermatol2020;183:966‚Äì968.86CooperSM,DeanD,AllenJetal.Erosivelichenplanusofthevulva:weakcirculatingbasementmembranezoneantibodiesarepresent.ClinExpDermatol2005;30:551‚Äì556.87MarrenP,MillardP,ChiaYetal.Mucosallichensclerosis/lichenplanusoverlapsyndromes.BrJDermatol1994;131:118‚Äì123.88DayT,MooreS,BohlTG,ScurryJ.Comorbidvulvarliche

---

### Chunk 7/30
**Article:** Lichen sclerosus: The 2023 update (2023)
**Journal:** Frontiers in Medicine
**Section:** results | **Similarity:** 0.662

ween clitoris and urethra and 
in the interlabial sulci, leading to dysuria (
95
). Due to intense pruritus, 
hyperkeratotic lesions and ecchymoses in the involved regions can 
beobserved. Mostly, clitoral hood, labia minora, inner part of labia 
majora, perineum and perianal region is aected (
Figure2B
), sometimes 
resembling ¬ìgure of eight,¬î also termed ¬ìkeyhole¬î or ¬ìhourglass,¬î with 
involvement of vulvar and perianal regions. Progression of disease can 
lead to scarring, which is observed in 80% of adult female patients and 
30% of girls (
11
). Scarring oen results in fusion or even complete 
resorption of labia minora and loss of clitoral hood. In addition, 
narrowing of vaginal introitus can occasionally lead to dyspareunia, 
strongly aecting sexual life of the patients (
5
).
In prepubertal girls, the clinical symptoms are similar to that of 
adult females, which oen present itch, soreness and sometimes dysuria.

---

### Chunk 8/30
**Article:** Lichen sclerosus: The 2023 update (2023)
**Journal:** Frontiers in Medicine
**Section:** other | **Similarity:** 0.658

nd Suarez, OA. Current treatment of lichen sclerosus and stricture. 
World J Urol
. (2020) 38:3061¬ñ7. doi: 
10.1007/s00345-019-03030-z
 189. Singh, N, Mishra, N, and Ghatage, P. Treatment options in vulvar lichen sclerosus: 
a scoping review. 
Cureus
. (2021) 13:e13527. doi: 
10.7759/cureus.13527
 190. Chmel, R, Nov√°ƒçkov√°, M, Fait, T, Z√°meƒçn√≠k, L, Krejƒçov√°, L, and Pastor, Z. Clitoral 
phimosis: eects on female sexual function and surgical treatment outcomes. 
J Sex Med
. 
(2019) 16:257¬ñ66. doi: 
10.1016/j.jsxm.2018.12.012
 191. Rouzier, R, Haddad, B, Deyrolle, C, Pelisse, M, Moyal-Barracco, M, and Paniel, BJ. 
Perineoplasty for the treatment of introital stenosis related to vulvar lichen sclerosus. 
Am 
J Obstet Gynecol
. (2002) 186:49¬ñ52. doi: 
10.1067/mob.2002.119186
 192. Gurumurthy, M, Morah, N, Giore, G, and Cruickshank, ME. e surgical 
management of complications of vulval lichen sclerosus. 
Eur J Obstet Gynecol Reprod Biol
. 
(2012) 162:79¬ñ82.

---

### Chunk 9/30
**Article:** Lichen sclerosus: The 2023 update (2023)
**Journal:** Frontiers in Medicine
**Section:** other | **Similarity:** 0.655

gins, CA, and Cruickshank, ME. A population-based case-control study of 
aetiological factors associated with vulval lichen sclerosus. 
J Obstet Gynaecol
. (2012) 
32:271¬ñ5. doi: 
10.3109/01443615.2011.649320

DeLuca et al. 
10.3389/fmed.2023.1106318
Frontiers in 
Medicine
16
frontiersin.org
 13. Singh, N, and Ghatage, P. Etiology, clinical features, and diagnosis of vulvar lichen 
sclerosus: a scoping review. 
Obstet Gynecol Int
. (2020) 2020:1¬ñ8. doi: 
10.1155/2020/7480754
 14. Krapf, JM, Smith, AB, Cigna, ST, and Goldstein, AT. Presenting symptoms and 
diagnosis of vulvar lichen sclerosus in premenopausal women: a cross-sectional study. 
J Low Genit Tract Dis
. (2022) 26:271¬ñ5. doi: 
10.1097/LGT.0000000000000679
 15. Goldstein, AT, Marino, SC, Christopher, K, and Srodon, M. Prevalence of vulvar 
lichen sclerosus in a general gynecology practice. 
J Reprod Med
. (2005) 50:477¬ñ80. PMID: 
16130842
 16. Kizer, WS, Prarie, T, and Morey, AF.

---

### Chunk 10/30
**Article:** 2021 European guideline for the management of vulval conditions (2022)
**Journal:** Journal of the European Academy of Dermatology and Venereology
**Section:** abstract | **Similarity:** 0.653

Vulvallichensclerosus,Vulvallichenplanus,Vul-valeczema,Vulvallichensimplex,Vulvalpsoriasis,Vulval
intraepithelialneoplasia,High-gradeSILofthevulva,vulval
HSIL,Vulvalpainsyndromes/vulvodynia.ScopeThisguidelinecoversthemorecommonconditionsaffectingthe
vulva:1Vulvaldermatitis(eczema)2Psoriasis
3Lichensimplexchronicus
4Lichensclerosus5Lichenplanus6Vulvodynia
7Vulvalintraepithelialneoplasia(VIN)GeneraladvicefordeliveryofvulvalcareVulvalconditionsmaypresenttoavarietyofcliniciansincluding
dermatologists,genitourinarymedicinephysicians,gynaecolo-
gistsandprimarycarephysiciansorgeneralpractitioners(GP).
Investigationsandmanagementspanacrossthisspectrum,so
womenwithvulvalconditionsarebestmanagedbyamultidisci-
plinaryapproach,whichincludesclearreferralpathways
betweendisciplinesoraccesstoaspecialistmultidisciplinary¬©2022EuropeanAcademyofDermatologyandVenereologyJEADV2022
DOI:10.1111/jdv.18102JEADV

---

### Chunk 11/30
**Article:** 2021 European guideline for the management of vulval conditions (2022)
**Journal:** Journal of the European Academy of Dermatology and Venereology
**Section:** discussion | **Similarity:** 0.653

7;9:631‚Äì642.151VincentK,EvansE.Anupdateonthemanagementofchronicpelvicpaininwomen.Anaesthesia2021;76(Suppl4):96‚Äì107.152AndrewsJC.Vulvodyniainterventions‚Äìsystematicreviewandevidencegrading.ObstetGynecolSurv2011;66:299‚Äì315.153Corsini-MuntS,RancourtKM,DubeJP,RossiMA,RosenNO.Vulvo-dynia:aconsiderationofclinicalandmethodologicalresearchchallenges
andrecommendedsolutions.JPainRes2017;10:2425‚Äì2436.154RosenNO,BergeronS,PukallCF.Recommendationsforthestudyofvulvarpaininwomen,part2:methodologicalchallenges.JSexMed2020;17:595‚Äì602.155MirandaVarellaPereiraG,SorianoMarcolinoM,SilveiraNogueiraReisZ,deCastroV,MonteiroM.Asystematicreviewofdrugtreatmentof¬©2022EuropeanAcademyofDermatologyandVenereologyJEADV2022
VulvalconditionsEuropeanguideline19

vulvodynia:evidenceofastrongplaceboeffect.BJOGIntJObstetGynaecol2018;125:1216‚Äì1224.156WeinbergerJM,HoumanJ,CaronATetal.Femalesexualdysfunctionandtheplaceboeffect:ameta-analysis.ObstetGynecol2018;132:453‚Äì458.157FosterDC,KotokMB,HuangL-Setal.Orald

---

### Chunk 12/30
**Article:** 2021 European guideline for the management of vulval conditions (2022)
**Journal:** Journal of the European Academy of Dermatology and Venereology
**Section:** other | **Similarity:** 0.653

eivednospecicgrantfromanyfundingagencyinthepublic,commercialornot-for-protsectors.Changestothisguidelinesincethe2015version:ÔøΩEvaluationscaleforgenitalpsoriasislesionsÔøΩUseofixekizumab,secukinumabandustekinumabintreat-inggenitalpsoriasisÔøΩDiagnosticcriteriaforvulvallichenplanusÔøΩChangedÔ¨Årstlinemanagementrecommendationsfor
vulvodyniaSearchstrategyÔøΩGuidelinesproducedbytheBritishAssociationforSexual
HealthandHIV(www.bashh.org)werereviewed.ÔøΩSearchedlibraries:MEDLINE,MEDLINEprocess,Embase,
Cochranelibrary.ÔøΩSearchuptoJune2021withnodatelimitation.Thesearch
strategycomprisedthefollowingtermsinthetitleorabstract:Vulvallichensclerosus,Vulvallichenplanus,Vul-valeczema,Vulvallichensimplex,Vulvalpsoriasis,Vulval
intraepithelialneoplasia,High-gradeSILofthevulva,vulval
HSIL,Vulvalpainsyndromes/vulvodynia.ScopeThisguidelinecoversthemorecommonconditionsaffectingthe
vulva:1Vulvaldermatitis(eczema)2Psoriasis
3Lichensimplexchronicus
4Lichensclerosus5Lichenplanus6Vulvodynia
7Vulvalintraepithe

---

### Chunk 13/30
**Article:** Lichen sclerosus: The 2023 update (2023)
**Journal:** Frontiers in Medicine
**Section:** other | **Similarity:** 0.652

nce of vulvar 
lichen sclerosus in a general gynecology practice. 
J Reprod Med
. (2005) 50:477¬ñ80. PMID: 
16130842
 16. Kizer, WS, Prarie, T, and Morey, AF. Balanitis xerotica obliterans: epidemiologic 
distribution in an equal access health care system. 
South Med J
. (2003) 96:9¬ñ11. doi: 
10.1097/00007611-200301000-00004
 17. Kantere, D, L√∂whagen, GB, Alvengren, G, M√•nesk√∂ld, A, Gillstedt, M, and 
Tunb√§ck, P. e clinical spectrum of lichen sclerosus in male patients- a retrospective 
study. 
Acta Derm Venereol
. (2014) 94:542¬ñ6. doi: 
10.2340/00015555-1797
 18. Leibovitz, A, Kaplun, VV, Saposhnicov, N, and Habot, B. Vulvovaginal examinations 
in elderly nursing home women residents. 
Arch Gerontol Geriatr
. (2000) 31:1¬ñ4. doi: 
10.1016/s0167-4943(00)00059-5
 19. Kirtschig, G. Lichen Sclerosus-presentation, diagnosis and management. 
Dtsch 
Arztebl Int
. (2016) 113:337¬ñ43. doi: 
10.3238/arztebl.2016.0337
 20. Nelson, DM, and Peterson, AC.

---

### Chunk 14/30
**Article:** Lichen sclerosus: The 2023 update (2023)
**Journal:** Frontiers in Medicine
**Section:** results | **Similarity:** 0.645

ed.15127
 207. Carli, P, Cattaneo, A, De Magnis, A, Biggeri, A, Taddei, G, and Giannotti, B. 
Squamous cell carcinoma arising in vulval lichen sclerosus: a longitudinal cohort study. 
Eur J Cancer Prev
. (1995) 4:491¬ñ6. doi: 
10.1097/00008469-199512000-00008
 208. Corazza, M, Borghi, A, Gaf√†, R, Ghirardi, C, and Ferretti, S. Risk of vulvar 
carcinoma in women aected with lichen sclerosus: results of a cohort study. 
J Dtsch 
Dermatol Ges
. (2019) 17:1069¬ñ71. doi: 
10.1111/ddg.13961
 209. Corazza, M, Schettini, N, Zedde, P, and Borghi, A. Vulvar lichen sclerosus from 
pathophysiology to therapeutic approaches: evidence and prospects. 
Biomedicine
. (2021) 
9:950. doi: 
10.3390/biomedicines9080950
 210. Murphy, R. Lichen sclerosus. 
Dermatol Clin
. (2010) 28:707¬ñ15. doi: 
10.1016/j.det.2010.07.006
 211. Micheletti, L, Preti, M, Radici, G, Boveri, S, Di Pumpo, O, Privitera, SS, et al. Vulvar 
lichen sclerosus and neoplastic transformation: a retrospective study of 976 cases.

---

### Chunk 15/30
**Article:** Lichen sclerosus: The 2023 update (2023)
**Journal:** Frontiers in Medicine
**Section:** other | **Similarity:** 0.639

los, K, Jahns, BG, Krause, E, Amann, E, Limacher, A, et al. 
Clinical scoring system for vulvar lichen sclerosus. 
J Sex Med
. (2012) 9:2342¬ñ50. doi: 
10.1111/j.1743-6109.2012.02814.x
 123. Naswa, S, and Marfatia, YS. Physician-administered clinical score of vulvar lichen 
sclerosus: a study of 36 cases. 
Indian J Sex Transm Dis AIDS
. (2015) 36:174¬ñ7. doi: 
10.4103/0253-7184.167169
 124. Lewis, FM, Tatnall, FM, Velangi, SS, Bunker, CB, Kumar, A, Brackenbury, F, et al. 
British Association of Dermatologists guidelines for the management of lichen sclerosus, 
2018. 
Br J Dermatol
. (2018) 178:839¬ñ53. doi: 
10.1111/bjd.16241
 125. Borghi, A, Corazza, M, Minghetti, S, Bianchini, E, and Virgili, A. Dermoscopic 
features of vulvar lichen sclerosus in the setting of a prospective cohort of patients: new 
observations. 
Dermatology
. (2016) 232:71¬ñ7. doi: 
10.1159/000439198
 126. Ankad, BS, and Beergouder, SL. Dermoscopic patterns in lichen sclerosus: a report 
of three cases.

---

### Chunk 16/30
**Article:** Lichen sclerosus: The 2023 update (2023)
**Journal:** Frontiers in Medicine
**Section:** other | **Similarity:** 0.637

Ganesan, AK, Taylor, TH, and Kraus, CN. Association of vulvar lichen sclerosus 
with endometrial and ovarian cancer. 
JAAD Int
. (2022) 9:26¬ñ7. doi: 
10.1016/j.
jdin.2022.07.003
 221. Moreno-V√≠lchez, C, Llobera-Ris, C, Torrecilla-Vall-Llossera, C, Notario, J, and 
Figueras-Nart, I. Lichen sclerosus and its association with cancer: a retrospective cohort 
study. 
Int J Dermatol
. (2022) 62:e84¬ñ5. doi: 
10.1111/ijd.16218
. [Epub ahead of print]
 222. Sivalingam, V, and Tamber, K. Understanding the impact of life with vulval lichen 
sclerosus. 
Br J Dermatol
. (2022) 187:840. doi: 
10.1111/bjd.21846
. [Epub ahead of print]
 223. Ranum, A, and Pearson, DR. e impact of genital lichen sclerosus and lichen 
planus on quality of life: a review. 
Int J Womens Dermatol
. (2022) 8:e042. doi: 
10.1097/
JW9.0000000000000042
 224. Hagedorn, M, Buxmeyer, B, Schmitt, Y, and Bauknecht, T. Survey of genital lichen 
sclerosus in women and men. 
Arch Gynecol Obstet
. (2002) 266:86¬ñ91.

---

### Chunk 17/30
**Article:** 2021 European guideline for the management of vulval conditions (2022)
**Journal:** Journal of the European Academy of Dermatology and Venereology
**Section:** other | **Similarity:** 0.636

72.93SimpsonRC,ThomasKS,LeightonP,MurphyR.Diagnosticcriteriaforerosivelichenplanusaffectingthevulva:aninternationalelectronic-Del-
phiconsensusexercise.BrJDermatol2013;169:337‚Äì343.94WuM,LeeG,AustralasFG,DermatolJ.Formingdiagnosticcriteriaforvulvarlichenplanus.AustralasJDermatol2020;61:324‚Äì329.95BorghiA,CorazzaM,MinghettiS,VirgilliA.Preliminarystudyonder-moscopicfeaturesofvulvarlichenplanus:newinsightsfordiagnosis.

---

### Chunk 18/30
**Article:** Lichen sclerosus: The 2023 update (2023)
**Journal:** Frontiers in Medicine
**Section:** other | **Similarity:** 0.633

own, C, Heiman, J, Leiblum, S, Meston, C, Shabsigh, R, et al. e female 
sexual function index (FSFI): a multidimensional self-report instrument for the assessment 
of female sexual function. 
J Sex Marital er
. (2000) 26:191¬ñ208. doi: 
10.1080/009262300278597
 134. Finlay, AY, and Khan, GK. Dermatology life quality index (DLQI)--a simple 
practical measure for routine clinical use. 
Clin Exp Dermatol
. (1994) 19:210¬ñ6. doi: 
10.1111/j.1365-2230.1994.tb01167.x
 135. Topp, CW, √òstergaard, SD, S√∏ndergaard, S, and Bech, P. e WHO-5 well-being 
index: a systematic review of the literature. 
Psychother Psychosom
. (2015) 84:167¬ñ76. doi: 
10.1159/000376585
 136. Vyas, A. Genital lichen sclerosus and its mimics. 
Obstet Gynecol Clin N Am
. (2017) 
44:389¬ñ406. doi: 
10.1016/j.ogc.2017.05.004
 137. Kirtschig, G. Lichen sclerosus: symptomatik, diagnostik, therapeutisches procedere. 
Hautarzt
. (2018) 69:127¬ñ33. doi: 
10.1007/s00105-017-4121-2
 138. Nguyen, ATM, and Holland, AJA.

---

### Chunk 19/30
**Article:** 2021 European guideline for the management of vulval conditions (2022)
**Journal:** Journal of the European Academy of Dermatology and Venereology
**Section:** results | **Similarity:** 0.632

ingdermatosis);thiscanpre-
sentwithsymmetricalerythema.InvestigationAbiopsyisrarelynecessarybutoneshouldbeperformedifthere
areatypicalfeaturesorfailuretorespondtotreatment(GRADE1,D).Patchtestingisusefulifanallergiccontactdermatitisissus-pected,butisnotnecessaryforalltypesofdermatitis.Patchtest-ingshouldbeperformedinacliniccompetentinthis
investigationandinterpretationoftheresults(GRADE1,B).Inadditiontothestandardbaselineseriesofallergens,anypatient
withasuspectedvulvalallergiccontactdermatitisshouldbe
testedtomedicaments,preservativesandanyspeciÔ¨Åcproducts
appliedbythepatienttothevulva,attheappropriatedilu-
tions.8,9Therelevanceoftheresultsmustbeassessedcarefully,asapositivetestdoesnotnecessarilymeanthatthetestedprod-uctisresponsibleforthevulvalrash.Conversely,anegativetest
cannotcompletelyprovetheinnocenceofatopicallyapplied
product.Appropriateswabswillexcludecandidiasisandbacterialinfection.Skinscrapingswillhelptoruleouttineacruris.Management1Avoidanceofirritantsandpossibleallergens

---

### Chunk 20/30
**Article:** 2021 European guideline for the management of vulval conditions (2022)
**Journal:** Journal of the European Academy of Dermatology and Venereology
**Section:** introduction | **Similarity:** 0.631

tientshavea
personalorimmediatefamilyhistoryofatopy5ÔøΩPrimaryoridiopathiclichensimplexchronicusdevelops
onabackgroundofnormalvulvalskin,usuallyin
atopicsÔøΩSecondarylichensimplexchronicusissuperimposedon
itchyvulvaldermatoses,suchaseczema,psoriasis,lichen
sclerosusorafungaloryeastinfection.13Theconditionistriggeredbypsychologicaldistress,suchasanxiety,depressionandobsessive-compulsivedisorder,andlocal
environmentalfactors,suchasheat,sweating,drynessofthe
skin,frictionandharshskincareproducts.Otherpredisposing¬©2022EuropeanAcademyofDermatologyandVenereologyJEADV2022
VulvalconditionsEuropeanguideline5

conditionsarethosewhichcausegeneralizedpruritisforexam-pleuraemia,liverdiseaseandthyroiddisease.Althoughprobably
rare,itmaysometimesbeworthwhiletoconsiderneuropathic
itchasapossiblecause.Thiscouldbeassociatedwithsacralspi-
nalcompression,postherpeticneuralgiaanddiabeticneuropa-thy.44Epidermalhyperinnervationseemstohaveanimportantroleinpersistentitching.45SymptomsÔøΩChronicorintermittentse

---

### Chunk 21/30
**Article:** 2021 European guideline for the management of vulval conditions (2022)
**Journal:** Journal of the European Academy of Dermatology and Venereology
**Section:** discussion | **Similarity:** 0.631

owdiscussionandreviewofhistologyresults.PhysicalexaminationofthepatientInformedconsentisapre-requisiteforallexaminations,investi-gationsandtreatments.Consentisparticularlyimportantforintimateexaminationsoftheanogenitalarea.Achaperone
shouldbeofferedinallcasesandthisshouldbedocumented
clearlyinthepatientrecords.Theproposedexaminationshould
beadequatelyexplainedtopatientsbeforetheyundress.All
attemptsshouldbemadetomaintainpatients‚Äôdignity,provid-
ingprivacytodressandundress,andkeepingthemcoveredas
muchaspossible.Appropriatefacilitiesandequipmentforinvestigationsshouldbeavailablepriortocommencingtheexamination.Theroomshouldbewelllit,privateandsound-
proofed,withasuitableexaminationcouchofadjustable
height.1DermatosesandSTIsmayco-existorawomanwithapre-existingdermatosismaycontractanSTI.Screeningforsexually
transmittedinfections(STI)shouldbeconsideredinallpatients,
dependingonsymptomsandriskfactors.Ifthepatientpresentswithvulvalitch,particularlywithincreaseddischarge,vulvovagi-nalcandidia

---

### Chunk 22/30
**Article:** Lichen sclerosus: The 2023 update (2023)
**Journal:** Frontiers in Medicine
**Section:** other | **Similarity:** 0.631

of lubricant to avoid painful intercourse, lifelong regular self-examination.
GPP
Discuss the amount of topical treatment, the site of application and the safe use of topical steroids in lichen sclerosus.
‚¨Ü
Consider intralesional triamcinolone in LS with topical steroid-resistant or hyperkeratotic areas, when malignancy has been excluded by biopsy.
GPP
All people treated for LS should befollowed up
Recommendations for female adult patients
‚¨Ü‚¨Ü
Oer clobetasol propionate 0,05% ointment for 3 months in anogenital LS (once a day the rst month, every other day the second month and twice weekly for the 
last month)
‚¨Ü‚¨Ü
Oer continued use of clobetasol propionate 0,05% for ongoing active disease
‚¨Ü
Consider an individualized treatment regimen of topical steroid to maintain disease control and prevent scarring in female patients with ongoing active LS disease 
despite good compliance.

---

### Chunk 23/30
**Article:** Lichen sclerosus: The 2023 update (2023)
**Journal:** Frontiers in Medicine
**Section:** discussion | **Similarity:** 0.629

comprehensive review of clinical features and treatment. 
Arch Dermatol Res
. (2022). doi: 
10.1007/s00403-022-02397-1
. [Epub ahead of print]
 103. Bevans, SL, Keeley, JM, and Sami, N. Oral lichen sclerosus-a review of clinical 
presentation, treatment, and clinical outcomes. 
Oral Surg Oral Med Oral Pathol Oral 
Radiol
. (2017) 124:e243¬ñ8. doi: 
10.1016/j.oooo.2017.07.005
 104. Kakko, T, Salo, T, and Siponen, MK. Oral lichen sclerosus: a systematic review of 
reported cases and two new cases. 
Int J Dermatol
. (2018) 57:521¬ñ8. doi: 
10.1111/
ijd.13870
 105. Niamh, L, Naveen, S, and Hazel, B. Diagnosis of vulval inammatory dermatoses: 
a pathological study with clinical correlation. 
Int J Gynecol Pathol
. (2009) 28:554¬ñ8. doi: 
10.1097/PGP.0b013e3181c7d5
 106. Morrel, B, Ewing-Graham, PC, van der Avoort, IAM, Pasmans, SGMA, and 
Damman, J. Structured analysis of histopathological characteristics of vulvar lichen 
sclerosus in a juvenile population. 
Hum Pathol
.

---

### Chunk 24/30
**Article:** 2021 European guideline for the management of vulval conditions (2022)
**Journal:** Journal of the European Academy of Dermatology and Venereology
**Section:** other | **Similarity:** 0.626

  behavioraltherapy,surfaceelectromyographicbiofeed-back,andvestibulectomyinthetreatmentofdyspareuniaresultingfrom
vulvarvestibulitis.Pain2001;91:297‚Äì306.206JonesRW,RowanDM,StewartAW.Vulvarintraepithelialneoplasia:aspectsofthenaturalhistoryandoutcomein405women.ObstetGyne-col2005;106:1319‚Äì1326.207HudeloML,CailliauO.Dyskeratoseerythroplasiformedelamusqueusevulvaire.BullSocFrancDermatolEtSyph1922;29:139‚Äì142.208BornsteinJ,BogliattoF,HaefnerHKetal.The2015internationalsocietyforthestudyofvulvovaginaldiasease(ISSVD)terminology
ofvulvarsquamousintraepitheliallesions.JLowerGenTractDis2016;20:11‚Äì14.209FriedrichEG.Reportofthecommitteeonterminology.Newnomencla-tureforvulvardisease.ObstetGynecol1976;49:122‚Äì124.210WilkinsonEJ,KnealeB,LynchPJ.ReportoftheISSVDterminologycommittee.ReprodMed1986;31:973‚Äì974.211SideriM,JonesRW,WilkinsonEJetal.Squamousvulvarintraepithelialneoplasia:2004modiÔ¨Åedterminology,ISSVDvulvaroncologysubcom-
mittee.JReprodMed2005;50:807‚Äì810212JouraEA.Epidemiology,diag

---

### Chunk 25/30
**Article:** Lichen sclerosus: The 2023 update (2023)
**Journal:** Frontiers in Medicine
**Section:** other | **Similarity:** 0.623

Biol
. (2008) 137:56¬ñ60. doi: 
10.1016/j.ejogrb.2007.10.005
 77. G√ºnthert, AR, Limacher, A, Beltraminelli, H, Krause, E, Mueller, MD, Trelle, S, et al. 
Ecacy of topical progesterone versus topical clobetasol propionate in patients with vulvar 
lichen sclerosus- a double-blind randomized phase II pilot study. 
Eur J Obstet Gynecol 
Reprod Biol
. (2022) 272:88¬ñ95. doi: 
10.1016/j.ejogrb.2022.03.020
 78. Prowse, DM, Ktori, EN, Chandrasekaran, D, Prapa, A, and Baithun, S. Human 
papillomavirus-associated increase in p16INK4A expression in penile lichen sclerosus and 
squamous cell carcinoma. 
Br J Dermatol
. (2008) 158:261¬ñ5. doi: 
10.1111/j.1365-2133.2007.08305.x
 79. de Martino, M, Haitel, A, Wrba, F, Schatzl, G, Klatte, T, and Waldert, M. High-risk 
human papilloma virus infection of the foreskin in asymptomatic boys. 
Urology
. (2013) 
81:869¬ñ72. doi: 
10.1016/j.urology.2012.12.011
 80. Edmonds, E, Barton, G, Buisson, S, Francis, N, Gotch, F, Game, L, et al.

---

### Chunk 26/30
**Article:** 2021 European guideline for the management of vulval conditions (2022)
**Journal:** Journal of the European Academy of Dermatology and Venereology
**Section:** other | **Similarity:** 0.622

present.ClinExpDermatol2005;30:551‚Äì556.87MarrenP,MillardP,ChiaYetal.Mucosallichensclerosis/lichenplanusoverlapsyndromes.BrJDermatol1994;131:118‚Äì123.88DayT,MooreS,BohlTG,ScurryJ.Comorbidvulvarlichenplanusandlichensclerosus.JLowGenitTractDis2017;21:204‚Äì208.89GoncalvesDLM,RomeroRL,FerreiraPL,SantiCG.Clinicalandepide-miologicalproÔ¨Åleofpatientsattendedinavulvarclinicofthedermatol-
ogyoutpatientunitofatertiaryhospitalduringa4-yearperiod.IntJDermatol2019;58:1311‚Äì1316.90LewisFM,ShahM,HarringtonCI.Vulvalinvolvementinlichenplanus:astudyof37women.BrJDermatol1996;135:89‚Äì91.91CooperSM,WojnarowskaF.InÔ¨Çuenceoftreatmentoferosivelichenplanusofthevulvaonitsprognosis.ArchDermatol2006;142:289‚Äì294.92GenadryR,ProvostTT.Severevulvarscarringinpatientswitherosivelichenplanus.JReprodMed2006;51:67‚Äì72.93SimpsonRC,ThomasKS,LeightonP,MurphyR.Diagnosticcriteriaforerosivelichenplanusaffectingthevulva:aninternationalelectronic-Del-
phiconsensusexercise.BrJDermatol2013;169:337‚Äì343.94WuM,LeeG,Austral

---

### Chunk 27/30
**Article:** 2021 European guideline for the management of vulval conditions (2022)
**Journal:** Journal of the European Academy of Dermatology and Venereology
**Section:** other | **Similarity:** 0.621

aginalinÔ¨Çammation;(vi)involve-mentofothermucosalsurfaces;(vii)presenceofawell-deÔ¨ÅnedinÔ¨Çammatorybandinvolvingthedermo-epidermal
junction;(viii)presenceofaninÔ¨Çammatorybandconsisting
predominantlyoflymphocytes;and(ix)signsofbasallayer
degeneration.Arecentstudy94of243womenwithclinicallysuspectedvulvalLPwithavailablehistopathology,50patientswith
biopsy-provenvulvarLSand50patientswithculture-provenchronicvulvovaginalcandidiasisconcludedthatclinicalfea-turesthatsigniÔ¨Åcantlydifferentiatedtheconditionswerethe
presenceoferosions,glazederythema,oralinvolvement,pain/
burningsensationandahyperkeratoticborder.Ascore‚â•2cor-relatedwithahistopathologicaldiagnosisofvulvarLP,witha
sensitivityof100%andaspeciÔ¨Åcityof92%and88%when
comparedagainstvulvarLSandchronicvulvovaginalcandidi-
asis,respectively.Involvementofthevaginapracticallyexcludeslichensclero-sus,whichtypicallysparesnon-keratinizedmucosalsurfaces.

---

### Chunk 28/30
**Article:** Lichen sclerosus: The 2023 update (2023)
**Journal:** Frontiers in Medicine
**Section:** other | **Similarity:** 0.620

J Dermatol
. (2013) 168:362¬ñ6. doi: 
10.1111/j.
1365-2133.2012.11201.x
 119. Eberz, B, and Regauer, S. Assoziation von anogenitalem Lichen sclerosus und 
Psoriasis bei erwachsenen Frauen. 
Geburtshilfe Frauenheilkd
. (2008) 68:32. doi: 
10.1055/
s-2008-1078319
 120. Ranum, A, Freese, R, Ramesh, V, and Pearson, DR. Lichen sclerosus in female 
patients is associated with an increased risk of metabolic syndrome and cardiovascular 
comorbidities: a retrospective cohort review. 
Br J Dermatol
. (2022) 187:1030¬ñ2. doi: 
10.1111/bjd.21811
. [Epub ahead of print]
 121. Yeon, J, Oakley, A, Olsson, A, Drummond, C, Veysey, E, Marshman, G, et al. Vulval 
lichen sclerosus: an Australasian management consensus. 
Australas J Dermatol
. (2021) 
62:292¬ñ9. doi: 
10.1111/ajd.13594
 122. G√ºnthert, AR, Duclos, K, Jahns, BG, Krause, E, Amann, E, Limacher, A, et al. 
Clinical scoring system for vulvar lichen sclerosus. 
J Sex Med
. (2012) 9:2342¬ñ50. doi: 
10.1111/j.1743-6109.2012.02814.x
 123.

---

### Chunk 29/30
**Article:** Lichen sclerosus: The 2023 update (2023)
**Journal:** Frontiers in Medicine
**Section:** other | **Similarity:** 0.620

Mod Pathol
. (2006) 19:504¬ñ13. doi: 
10.1038/
modpathol.3800532
 57. Liegl, B, and Regauer, S. p53 immunostaining in lichen sclerosus is related to 
ischaemic stress and is not a marker of dierentiated vulvar intraepithelial neoplasia 
(d-VIN). 
Histopathology
. (2006) 48:268¬ñ74. doi: 
10.1111/j.1365-2559.2005.02321.x
 58. Vanin, K, Scurry, J, orne, H, Yuen, K, and Ramsay, RG. Overexpression of wild-
type p53in lichen sclerosus adjacent to human papillomavirus-negative vulvar cancer. 
J 
Invest Dermatol
. (2002) 119:1027¬ñ33. doi: 
10.1046/j.1523-1747.2002.19513.x
 59. Kirby, L, Gran, S, Orekoya, F, Owen, C, and Simpson, R. Is urinary incontinence 
associated with vulval lichen sclerosus in women? A crosssectional study. 
Br J Dermatol 
Syph
. (2021) 185:1063¬ñ5. doi: 
10.1111/bjd.20583
 60. Panou, E, Panagou, E, Foley, C, Kravvas, G, Watchorn, R, Alnajjar, H, et al.

---

### Chunk 30/30
**Article:** 2021 European guideline for the management of vulval conditions (2022)
**Journal:** Journal of the European Academy of Dermatology and Venereology
**Section:** other | **Similarity:** 0.620

apyisconsidered.Follow-upÔøΩAt2‚Äì3monthstoassessresponsetotreatment.ÔøΩActivediseaseshouldbeassessedasclinicallyrequired.Ero-sivevulvalLPneedslong-termspecializedfollow-up.ÔøΩStablediseaseshouldbereviewedannually,exceptinwell-
counselledpatientswhocontroltheirsymptomswell.If
reviewistobeundertakenbytheGP,thisshouldbecom-municatedtothepatientandGPbytheclinic.ÔøΩPatientsshouldbeadvisedtoseekurgentmedicaladviceiftheynoticeachangeinappearanceortexture(e.g.lump,
hardeningofskinorpersistentulceration).VulvodyniaVulvodyniaisdeÔ¨Ånedas‚Äòvulvarpainofatleast3months‚Äôdura-
tion,withoutaclearidentiÔ¨Åablecause,whichmayhavepotential
associatedfactors‚Äô.121Itiscategorizedasgeneralizedorlocalized,andprovoked,unprovokedormixed(bothprovokedand
unprovoked;seesymptoms).Accordingtothelastversionofthe
DiagnosticandStatisticalManualofMentalDisorders(DSM-5),vulvodyniacanbeconsideredasafemalegenito-pelvicpain/penetrationdisorder.122‚Äì125AetiologyVulvodyniaiscurrentlyconsideredasadysfunctionalsensorypro-c

---

